Rectal cancer in egyptian patients under 45 years : A clinical description with pathological referenc / Mohammed Mohammed Mostafa Balbola ; Supervised Osama Ahmed Almalt , Noha Elsayed Ezzat , Tarek Sherif Elbaradie
Material type:
- سرطان المستقيم في المصريين تحت٤٥سنة : وصف اكلينيكى و باثولوجي [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2016.Mo.R (Browse shelf(Opens below)) | Not for loan | 01010110069889000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2016.Mo.R (Browse shelf(Opens below)) | 69889.CD | Not for loan | 01020110069889000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology - Surgical
In Egypt, a clearly higher prevalence of early-onset rectal cancer was found than in the western world. Objectives: To describe rectal cancer in Egyptian patients 45 years of age and younger to report the clinical and pathological characteristics along with the outcome of this unique subgroup of patients. Patients and methods: A retrospective case series was undertaken. It included all patients 45 years old or less at time of diagnosis who presented or had been referred to National Cancer Institute (NCI), Cairo University with rectal cancer during the time interval from 2008 to 2010. Results: The incidence of rectal cancer in patients 45 years old and younger in relation to rectal cancer in all age groups was found to be (37.6%). The commonest histological cell type was adenocarcinoma ordinary type (57.2%), followed by mucinous (25.2%), then signet ring adenocarcinoma (7.7%). The pathologic complete response (pCR) was observed in 7.7% of patients. 15.35% of patients developed locoregional recurrence. The median overall survival for our patients was 26.8 months and the median disease free survival was 62.6 months
Issued also as CD
There are no comments on this title.